Leveraging Real World Data in Life Sciences Marketing

This white paper discusses the challenges faced by life sciences companies in effectively marketing new treatments and the role of real world data (RWD) in overcoming these obstacles. It outlines how traditional marketing methodologies are insufficient in the current healthcare landscape, necessitating a more comprehensive understanding of the patient journey and healthcare ecosystem. The paper emphasizes the importance of leveraging RWD to gain insights into patient experiences, which can enhance brand planning, launch, and management. It details the need for commercial teams to reinvent their go-to-market strategies, highlighting issues such as incomplete data views and the inability to demonstrate brand value. Furthermore, it presents how RWD can be utilized to respond to crises, like the COVID-19 pandemic, and improve patient engagement through personalized treatment approaches. The paper concludes by stressing the necessity for life sciences marketing teams to adapt to these changes to fulfill their missions effectively.